Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-11 4:00 pm Purchase | 2026-03-09 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 11,969,079 12.900% | 34,400 (+0.29%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | Opus Genetics, Inc. IRD | PERCEPTIVE ADVISORS LLC | 7,174,154 9.990% | 2,663,653 (+59.05%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | Tenax Therapeutics, Inc. TENX | PERCEPTIVE ADVISORS LLC | 569,308 9.100% | 130,166 (+29.64%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | Celcuity Inc. CELC | PERCEPTIVE ADVISORS LLC | 3,160,200 6.800% | 489,603 (+18.33%) | Filing History |
| 2026-02-17 4:00 pm Unchanged | 2025-12-31 | 13G | Adagio Medical Holdings, Inc. ADGM | PERCEPTIVE ADVISORS LLC | 15,321,655 57.500% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | Alto Neuroscience, Inc. ANRO | PERCEPTIVE ADVISORS LLC | 3,249,934 9.990% | 1,260,541 (+63.36%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | Palisade Bio, Inc. PALI | PERCEPTIVE ADVISORS LLC | 15,200,117 9.990% | 2,957,099 (+24.15%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | PERCEPTIVE ADVISORS LLC | 12,816,643 9.990% | 6,016,699 (+88.48%) | Filing History |
| 2026-02-17 4:00 pm Sale | 2025-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX | PERCEPTIVE ADVISORS LLC | 4,185,632 7.000% | -1,036,679 (-19.85%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | PERCEPTIVE ADVISORS LLC | 1,995,986 7.200% | 633,483 (+46.49%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | enVVeno Medical Corporation NVNO | PERCEPTIVE ADVISORS LLC | 2,048,515 9.990% | 1,995,109 (+3735.72%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | Bright Minds Biosciences Inc. DRUG | PERCEPTIVE ADVISORS LLC | 449,290 4.600% | 4,641 (+1.04%) | Filing History |
| 2026-02-17 4:00 pm Sale | 2025-12-31 | 13G | Travere Therapeutics, Inc. TVTX | PERCEPTIVE ADVISORS LLC | 4,278,180 4.800% | -617,435 (-12.61%) | Filing History |
| 2026-02-09 5:03 pm Sale | 2026-01-26 | 13D | Astria Therapeutics, Inc. ATXS | PERCEPTIVE ADVISORS LLC | 0 0.000% | -6,485,420 (Position Closed) | Filing History |
| 2026-01-26 5:19 pm Sale | 2026-01-22 | 13D | Trinity Biotech plc TRIB | PERCEPTIVE ADVISORS LLC | 1,463,058,248 9.900% | -35,800,003 (-2.39%) | Filing History |
| 2026-01-22 4:34 pm Purchase | 2026-01-14 | 13G | SAB Biotherapeutics, Inc. SABS | PERCEPTIVE ADVISORS LLC | 3,471,861 7.300% | 3,471,861 (New Position) | Filing History |
| 2026-01-16 4:46 pm Sale | 2026-01-16 | 13D | LeonaBio, Inc. LONA | PERCEPTIVE ADVISORS LLC | 1,859,322 19.990% | -9,728 (-0.52%) | Filing History |
| 2026-01-02 4:20 pm Sale | 2025-12-31 | 13D | MeiraGTx Holdings plc MGTX | PERCEPTIVE ADVISORS LLC | 10,441,562 12.900% | -2,255,000 (-17.76%) | Filing History |
| 2025-12-23 5:16 pm Purchase | 2025-12-23 | 13D | LeonaBio, Inc. LONA | PERCEPTIVE ADVISORS LLC | 1,869,050 20.100% | 1,319,026 (+239.81%) | Filing History |
| 2025-12-23 4:49 pm Purchase | 2025-12-22 | 13D | Trinity Biotech plc TRIB | PERCEPTIVE ADVISORS LLC | 1,498,858,251 9.900% | 1,398,058,251 (+1386.96%) | Filing History |